A phase Ib study to evaluate the oral selective estrogen receptor degrader GDC-9545 alone or combined with palbociclib in metastatic ER-positive HER2-negative breast cancer Meeting Abstract
| Authors: | Lim, E.; Jhaveri, K. L.; Perez-Fidalgo, J. A.; Bellet, M.; Boni, V.; Garcia, J. M. P.; Estevez, L.; Bardia, A.; Turner, N. C.; Villanueva, R.; Cobo, S. L. T.; Im, S. A.; Kim, S. B.; Gates, M. R.; Monemi, S.; Chen, Y. C.; Moore, H.; Loi, S.; Sohn, J. |
| Abstract Title: | A phase Ib study to evaluate the oral selective estrogen receptor degrader GDC-9545 alone or combined with palbociclib in metastatic ER-positive HER2-negative breast cancer |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368300195 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.1023 |
| Notes: | Meeting Abstract: 1023 -- Source: Wos |
